Department of Radiology, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Shannxi, China.
BMC Cancer. 2010 Dec 29;10:693. doi: 10.1186/1471-2407-10-693.
To determine, in a meta-analysis, the diagnostic performance of quantitative diffusion-weighted (DW) MR imaging in patients with breast lesions.
English and Chinese studies published prior to June 2009 to assess the diagnostic performance of quantitative DWI in patients with breast lesions were reviewed and summarized with reference to the inclusion and exclusion criteria. Methodological quality was assessed by using the quality assessment of diagnostic studies (QUADAS) instrument. Publication bias analysis was performed by using Comprehensive Meta-analysis version 2. Meta-Disc version 1.4 was used to describe primary results and explore homogeneity by Chi-square test and inconsistency index; to explore threshold effect by receiver operator characteristic (ROC) space and Spearman correlation coefficient; and to pool weighted sensitivity and specificity by fixed or random effect model. A summary ROC (sROC) curve was constructed to calculate the area under the curve (AUC).
Of 65 eligible studies, 13 with 615 malignant and 349 benign lesions were included in the original meta-analysis, among which heterogeneity arising from factors other than threshold effect and publication bias was explored. Methodological quality was moderate. The pooled weighted sensitivity and specificity with corresponding 95% confidence interval (CI) in one homogenous subgroup of studies using maximum b = 1000 s/mm2 were 0.84 (0.80, 0.87) and 0.84 (0.79, 0.88) respectively. AUC of sROC was 0.9085. Sensitivity analysis demonstrated that the pooled estimates were stable and reliable.
Quantitative DWI has a higher specificity to differentiate between benign and malignant breast lesions compared to that of contrast-enhanced MRI. However, large scale randomized control trials (RCTs) are necessary to assess its clinical value because of disunified diffusion gradient factor b and diagnosis threshold.
通过荟萃分析确定定量扩散加权(DW)MR 成像在乳腺病变患者中的诊断性能。
对 2009 年 6 月之前发表的评估定量 DWI 在乳腺病变患者中的诊断性能的英文和中文研究进行了回顾和总结,并参考了纳入和排除标准。使用诊断研究质量评估(QUADAS)工具评估方法学质量。使用 Comprehensive Meta-Analysis version 2 进行发表偏倚分析。使用 Meta-Disc version 1.4 通过卡方检验和不一致指数描述主要结果并探索同质性;通过接收器工作特征(ROC)空间和斯皮尔曼相关系数探索阈值效应;通过固定或随机效应模型汇总加权敏感性和特异性。构建汇总受试者工作特征(sROC)曲线以计算曲线下面积(AUC)。
在 65 项合格研究中,有 13 项研究(共 615 例恶性和 349 例良性病变)纳入原始荟萃分析,其中探讨了源于阈值效应和发表偏倚以外因素的异质性。方法学质量为中等。在一个同质亚组研究中,使用最大 b = 1000 s/mm2 时,汇总的加权敏感性和特异性及其相应的 95%置信区间(CI)分别为 0.84(0.80,0.87)和 0.84(0.79,0.88)。sROC 的 AUC 为 0.9085。敏感性分析表明汇总估计值稳定可靠。
与对比增强 MRI 相比,定量 DWI 具有更高的特异性,可区分良性和恶性乳腺病变。然而,由于扩散梯度因子 b 和诊断阈值不统一,需要进行大规模的随机对照试验(RCT)来评估其临床价值。